坦德姆糖尿病护理
TNDM
16.24
-0.28
-1.69%
坦德姆糖尿病护理
US · TNDM
#3179 按市值排名
16.24
-0.28
-1.69%
实时 - 追踪5344个代码 - 心跳于10秒前
· 2026-10-16 19:30
✦ 量化股权信号 计算方式说明
减持
- 最近一期(2026/Q3)披露持股的机构数量减少了2家。
- 机构持股总比例下降了0.8个百分点。
机构持股
- 机构持股比例
- 115.99% -0.81pp
- 机构数量
- 333 -2
- 数据截至
- 2026/Q3 较上一报告期
持股变动 vs 资金流向
方向一致机构在上一报告期减持了股份,同时该股在最近20个交易日的主力资金呈净流出——两者方向一致。
机构持股变动数据按季度发布且存在滞后;资金流向数据为每日更新。请将其作为方向性的交叉验证参考,而非精确的择时信号。
持股人类型
Mutual Fund80.31%
Hedge Fund27.38%
Public Company4.04%
Sovereign Wealth Fund1.42%
Government Pension Fund1.40%
Private Company1.06%
Individual/Insider1.00%
Insurance Company0.29%
主要股东 截至 2026-06-30
BlackRock
16.65% · 11.58M 股
Sessa Capital IM, L.P.
7.33% · 5.10M 股
Vanguard Portfolio Management, LLC
6.18% · 4.30M 股
Vanguard Capital Management, LLC
5.16% · 3.59M 股
First Light Asset Management, LLC
4.86% · 3.38M 股
State Street Global Advisors
4.10% · 2.85M 股
GW&K Investment Management, LLC
3.69% · 2.57M 股
Jennison Associates LLC
3.35% · 2.33M 股
Paradice Investment Management Pty Ltd.
2.91% · 2.02M 股
Jacobs Levy Equity Management Inc
2.88% · 2.01M 股
条形长度是相对于此处列出的最大股东而言,并非相对于公司100%股权。
内部人持股
共追踪50份申报 · 36次买入 · 14次卖出
| 姓名 | 职务 | 持股比例 |
|---|---|---|
| John Sheridan | Chief Executive Officer | 0.23% |
| Leigh Vosseller | Chief Financial Officer | 0.11% |
| Susan Morrison | Executive Vice President | 0.08% |
| Dick Allen | Independent Director | 0.07% |
| Mark Novara | Executive Vice President | 0.06% |
| Christopher Twomey | Independent Director | 0.05% |
| Elizabeth Gasser | Chief Strategy Officer | 0.05% |
| Shannon Hansen | Chief Legal, Privacy & Compliance Officer and Secretary | 0.05% |
| Rick Carpenter | Chief Technology Officer | 0.05% |
| Jean-Claude Kyrillos | Chief Operating Officer | 0.04% |
内部人交易 最近的 Form 4 申报记录
| 日期 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-09-16 | Mark Novara | Executive Vice President | Intent to Sell (Form 144) | -360 | $17.53 |
| 2026-08-17 | Mark Novara | Executive Vice President | Intent to Sell (Form 144) | -131 | $22.26 |
| 2026-08-14 | Jean-Claude Kyrillos | Chief Operating Officer | Derivative Exercise and Sale | -535 | $22.72 |
| 2026-08-14 | Jean-Claude Kyrillos | Chief Operating Officer | Derivative Exercise and Retained | +475 | -- |
| 2026-08-14 | Shannon Hansen | Chief Legal, Privacy & Compliance Officer and Secretary | Derivative Exercise and Sale | -1,535 | $22.72 |
| 2026-08-14 | Shannon Hansen | Chief Legal, Privacy & Compliance Officer and Secretary | Derivative Exercise and Retained | +1,479 | -- |
| 2026-08-14 | John Sheridan | Chief Executive Officer | Derivative Exercise and Sale | -8,099 | $22.72 |
| 2026-08-14 | John Sheridan | Chief Executive Officer | Derivative Exercise and Retained | +7,817 | -- |
| 2026-08-14 | Leigh Vosseller | Chief Financial Officer | Derivative Exercise and Sale | -1,479 | $22.72 |
| 2026-08-14 | Leigh Vosseller | Chief Financial Officer | Derivative Exercise and Retained | +2,641 | -- |
| 2026-08-14 | Rick Carpenter | Chief Technology Officer | Derivative Exercise and Sale | -1,277 | $22.72 |
| 2026-08-14 | Rick Carpenter | Chief Technology Officer | Derivative Exercise and Retained | +1,230 | -- |
| 2026-08-14 | Susan Morrison | Executive Vice President | Derivative Exercise and Sale | -809 | $22.72 |
| 2026-08-14 | Susan Morrison | Executive Vice President | Derivative Exercise and Retained | +2,018 | -- |
| 2026-08-14 | Elizabeth Gasser | Chief Strategy Officer | Derivative Exercise and Sale | -1,618 | $22.72 |
| 2026-08-14 | Elizabeth Gasser | Chief Strategy Officer | Derivative Exercise and Retained | +1,396 | -- |
| 2026-07-14 | Jean-Claude Kyrillos | Chief Operating Officer | Derivative Exercise and Sale | -1,926 | $15.28 |
| 2026-07-14 | Jean-Claude Kyrillos | Chief Operating Officer | Derivative Exercise and Retained | +1,710 | -- |
| 2026-06-16 | Mark Novara | Executive Vice President | Intent to Sell (Form 144) | -361 | $16.69 |
| 2026-06-01 | Elizabeth Gasser | Chief Strategy Officer | Other Acquisition | +7,160 | -- |
Form 4 申报记录,每家公司显示最新的一批。"Other Derivative Acquisition"(其他衍生品获取)类目多为限制性股票/期权归属,并非公开市场买入——具体类型见"类型"列。
报价时间 2026-10-16 19:30:04 · 仅供参考,不构成投资建议,也未考虑您的具体情况。
坦德姆糖尿病护理 讨论区 0 条评论